ArticleInternational journal of clinical oncology2025

CD155 expression and co-expression with PD-L1 are not associated with poor prognosis in patients with stage II and III lung adenocarcinoma undergoing surgical resection.

Kyoto Matsudo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.